Human Hookworm Vaccine Initiative
Showing 1 - 25 of >10,000
Healthy Trial in Pretoria (H107e, CAF®10b, H107e/CAF®10b - low adjuvant dose)
Not yet recruiting
- Healthy
- H107e
- +10 more
-
Pretoria, Gauteng, South AfricaAurum Institute
Sep 24, 2023
Safety Markers of Adjuvanted Influenza Vaccine Trial in Ghent (Fluad, Saline)
Completed
- Safety Markers of Adjuvanted Influenza Vaccine
- Fluad
- Saline
-
Ghent, East-Flanders, BelgiumCenter for Vaccinology
Dec 19, 2022
Acute Human Immunodeficiency Virus Type I Infection Trial in Masaka
Recruiting
- Acute Human Immunodeficiency Virus Type I Infection
-
Masaka, UgandaMRC/UVRI & LSHTM, Uganda Research Unit,Masaka station
May 10, 2022
Malaria,Falciparum, Plasmodium Falciparum, Plasmodium Berghei Trial in Nijmegen, Rotterdam (Pb(PfCS@UIS4)-infected mosquitoes,
Completed
- Malaria,Falciparum
- +3 more
- Pb(PfCS@UIS4)-infected mosquitoes
- Challenge infection P. falciparum
-
Nijmegen, Gelderland, Netherlands
- +1 more
Feb 23, 2022
HIV Trial in Boston, Seattle, Nairobi (BG505 SOSIP.664 gp140, adjuvanted, Placebo)
Active, not recruiting
- HIV Infections
- BG505 SOSIP.664 gp140, adjuvanted
- Placebo
-
Boston, Massachusetts
- +2 more
May 6, 2022
HIV/AIDS Trial in Washington, Seattle (eOD-GT8 60mer + AS01B/ DPBS sucrose/IM, DPBS Sucrose)
Completed
- HIV/AIDS
- eOD-GT8 60mer + AS01B/ DPBS sucrose/IM
- DPBS Sucrose
-
Washington, District of Columbia
- +1 more
May 11, 2022
Tuberculosis, MDR Trial in Worldwide (Delamanid (DLM), Isoniazid (INH), Pyridoxine (vitamin B6))
Recruiting
- Tuberculosis, MDR
- Delamanid (DLM)
- +2 more
-
Gaborone, South-East District, Botswana
- +26 more
Sep 22, 2022
Vaccine Reaction Trial in New Haven (MicronJet, Fluzone® Quadrivalent)
Not yet recruiting
- Vaccine Reaction
- MicronJet
- Fluzone® Quadrivalent
-
New Haven, ConnecticutChurch Street Research Unit
Sep 27, 2023
Human Papillomavirus-Related Carcinoma Trial in Columbus (Educational Intervention, Informational Intervention, Survey
Recruiting
- Human Papillomavirus-Related Carcinoma
- Educational Intervention
- +2 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
May 9, 2022
Malaria,Falciparum, Gametocytes, Controlled Human Malaria Infection Trial in Nijmegen (Piperaquine (low dose), Piperaquine (high
Completed
- Malaria,Falciparum
- +3 more
- Piperaquine (low dose)
- +5 more
-
Nijmegen, Gelderland, NetherlandsRadboud university medical center
Jun 15, 2020
HIV-1-infection Trial in Amsterdam (ConM SOSIP.v7 gp140, adjuvanted with MPLA liposomes)
Active, not recruiting
- HIV-1-infection
- ConM SOSIP.v7 gp140, adjuvanted with MPLA liposomes
-
Amsterdam, Noord-Holland, NetherlandsAmsterdam University Medical Centers, location AMC
Jan 31, 2023
HPV, Stigma Trial (Heroes for Her, The Reach Initiative, W.H.I.T.E project)
Not yet recruiting
- HPV
- Stigma
- Heroes for Her
- +6 more
- (no location specified)
Aug 17, 2023
Hookworm Infections Trial in Chake Chake (Emodepside, Albendazole 400mg)
Not yet recruiting
- Hookworm Infections
- Emodepside
- Albendazole 400mg
-
Chake Chake, Pemba, TanzaniaPublic Health Laboratory Ivo de Carneri
Sep 9, 2022
SARS-CoV-2 Infection Trial in Baltimore (B/HPIV3/S-6P)
Recruiting
- SARS-CoV-2 Infection
- B/HPIV3/S-6P
-
Baltimore, MarylandJohns Hopkins Bloomberg School of Public Health
Aug 30, 2023
Hookworm Infection, Hookworm Disease Trial in Lambaréné (Na-GST-1, CPG 10104)
Completed
- Hookworm Infection
- Hookworm Disease
- Na-GST-1
- CPG 10104
-
Lambaréné, GabonCentre de Récherches Médicales de Lambaréné
Jan 12, 2021
Sudan Ebola Virus Vaccines Trial (CAd3, ChAdox1, rVSV-SUDV)
Not yet recruiting
- Sudan Ebola Virus Vaccines
- CAd3
- +3 more
- (no location specified)
Jun 8, 2023
Necator Americanus Infection Trial in Leiden (Necator americanus L3 larvae)
Completed
- Necator Americanus Infection
- Necator americanus L3 larvae
-
Leiden, NetherlandsLeiden University Medical Center
Dec 20, 2021
Influenza, Human Trial in Brisbane (ARCT-2138, Licensed Quadrivalent Vaccine for younger adults, Licensed Quadrivalent Vaccine
Not yet recruiting
- Influenza, Human
- ARCT-2138
- +2 more
-
Brisbane, Queensland, AustraliaNucleus Network Brisbane Clinic
Nov 8, 2023
HIV-1-infection Trial in Kenya, Uganda, Zambia (Vaccine, Placebo)
Active, not recruiting
- HIV-1-infection
- Vaccine
- Placebo
-
Kilifi, Kenya
- +3 more
Jun 21, 2022
Ebola Virus Disease Trial in Boende (Ad26.ZEBOV vaccine)
Completed
- Ebola Virus Disease
- Ad26.ZEBOV vaccine
-
Boende, Province De La Tshuapa, Congo, The Democratic Republic of theHôpital Général de Référence de Boende
Jan 3, 2023
COPD Exacerbation Acute Trial in Rochester (CUVITRU - Ig subcutaneous human 20%, Standard Medical Therapy)
Not yet recruiting
- COPD Exacerbation Acute
- CUVITRU - Ig subcutaneous human 20%
- Standard Medical Therapy
-
Rochester, New York
- +2 more
Feb 28, 2023
Coronavirus Trial (OVX033, Saline solution)
Not yet recruiting
- Coronavirus
- OVX033
- Saline solution
- (no location specified)
Nov 14, 2023
Diphtheria, Tetanus and Acellular Pertussis Trial (Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined
Not yet recruiting
- Diphtheria, Tetanus and Acellular Pertussis
- Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed (DTcP)
- +4 more
- (no location specified)
Jul 10, 2023
Respiratory Syncytial Virus, Human Metapneumovirus Trial in Worldwide (mRNA-1345, mRNA-1365, Placebo)
Recruiting
- Respiratory Syncytial Virus
- Human Metapneumovirus
- mRNA-1345
- +3 more
-
Andalusia, Alabama
- +72 more
Feb 15, 2023
Trichuris Trichiura; Infection, Hookworm Infections Trial in Chake Chake (Emodepside)
Completed
- Trichuris Trichiura; Infection
- Hookworm Infections
-
Chake Chake, TanzaniaPublic Health Laboratory - Ivo de Carneri
May 26, 2022